Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep420 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Flash glucose monitoring in DM1: Our experience in a secondary referral hospital

Serrano Laguna Ma del Carmen , Barrera-Martin Ana , Rebollo-Roman Angel , Silva-Fernandez Julia , Galvez Moreno Maria Angeles

Objective: Flash glucose monitoring (FGM) allows non-invasive glucose level assessment. Our objective was to describe the characteristics of patients in a secondary referral hospital and their glycemic control expressed as FGM targets.Methods and patientsObservational longitudinal clinical study between January 2021 and December 2021 in patients with DM1 referred to a secondary care center in Montilla (Córdoba).Results: 101 patients included. Mean a...

ea0090ep57 | Adrenal and Cardiovascular Endocrinology | ECE2023

Adrenal venous sampling in patients with hyperaldosteronism

Moyano-Sanchez Ana Maria , Rebollo-Roman Angel , Serrano Laguna Ma del Carmen , Moreno-Moreno Paloma , Galvez Moreno Maria Angeles

Objective: Adrenal venous sampling (AVS) is a reliable procedure to differentiate if in patients with primary aldosteronism (PA) aldosterone production is unilateral or bilateral and guide treatment of these patients. Our objective was to describe their characteristics and the outcomes of the AVS.Methods and patients: Observational longitudinal clinical study between July 2020 and November 2022 in patients who underwent AVS in our Hospital.<p class="...

ea0063gp207 | Diabetes: Pharmacotherapy | ECE2019

Treatment with sitagliptin in patients with type 1 diabetes and type LADA diabetes

Moreno-Moreno Paloma , Alhambra-Exposito Maria Rosa , Rebollo-Roman Angel , Martin-Barrera Ana , Galvez-Moreno Maria Angeles

Objective: Preclinical studies have shown that DPP-4 inhibitors (iDPP4) have beneficial effects on functional mass of beta cells and pancreatic insulin content. The aim of this study is to evaluate the efficacy of treatment with sitagliptin in monotherapy or in combination with insulin in person with type 1 diabetes (DM-1) or type LADA diabetes (DM-LADA) of recent diagnosis.Patients and methods: Descriptive study: patients with DM-1 or DM-LADA in treatme...

ea0063p576 | Diabetes, Obesity and Metabolism 2 | ECE2019

Myocardial infarction in diabetic patients and cardiovascular risk factors control

Alcantara-Laguna Maria , Rebollo-Roman Angel , Moreno-Moreno Paloma , Leon-Idougourram Soraya , Barrera-Martin Ana , Galvez-Moreno Maria-Angeles

Aim: Describe the control of cardiovascular risk factors (CVRF) in patients with diabetes and myocardial infarction (MI) as well as their treatment and control.Patients and methods: Observational retrospective study of a cohort of patients with diabetes admitted to the cardiology department because of a MI between November 2015 and November 2016. Statistical analysis performed with SPSS 24th version.Results: 421 patients admitted b...

ea0049ep159 | Endocrine tumours and neoplasia | ECE2017

Follow-up of adrenal incidentalomas after the initial approach

Rebollo-Roman Angel , Moreno-Moreno Paloma , Prior-Sanchez Inmaculada , Herrera-Martinez Aura-Dulcinea , Barrera-Martin Ana , Galvez-Moreno Maria-Angeles

Aim: To describe the follow-up of adrenal incidentalomas (AI) classified as non-functioning and no suspicious for malignancy in the first approach.Patients and methods: Observational retrospective study of a cohort of patients who consulted in the Endocrinology service between 2005 and 2015 because of an AI. Statistical analysis performed with SPSS 19th version.Results: Two hundred and one patients with IA were firstly evaluated. T...

ea0049ep500 | Diabetes complications | ECE2017

Overweight and obesity in pregnant with diabetes mellitus type 1

Moreno-Moreno Paloma , Rebollo-Roman Angel , Palomares-Ortega Rafael , Munoz-Jimenez Concepcion , Alhambra-Exposito Maria Rosa , Galvez-Moreno Maria Angeles

Objectives: Pregnant women who are overweight or obese have an increased risk of complications during pregnancy, as do pregnant women with type 1 diabetes mellitus (DM1). The objective of this study is to describe the prevalence of overweight/obesity in pregnant women with DM1, and associated complications.Patients and methods: Retrospective descriptive study of pregnant women with DM1 (2004–2014). Variables analyzed: age, initial body mass index (B...

ea0041ep757 | Neuroendocrinology | ECE2016

Persistence of obesity and overweight in patients with Cushing disease in remission

Moreno-Moreno Paloma , Rebollo-Roman Angel , Ibanez-Costa Alejandro , Alhambra-Exposito Maria Rosa , Munoz-Jimenez Concepcion , Galvez-Moreno Maria Angeles

Objective: Obesity and overweight persist in patients with Cushing’s disease (CD) in remission, its persistence seems to be related to the duration of the disease. The aim of this study was to describe the persistence of overweight/obesity in patients with CD in remission and their relation to the duration of the disease.Patients and methods: Descriptive study of patients with CD (1995-2015). Variables analyzed: age, sex, body mass index (BMI), time...

ea0056p820 | Pituitary - Clinical | ECE2018

Cushing disease after remission and prevalence of cardiovascular risk factors

Moreno-Moreno Paloma , Rebollo-Roman Angel , Alhambra-Exposito Maria Rosa , Munoz-Jimenez Concepcion , Galvez-Moreno Maria Angeles

Objective: Cardiovascular risk factors (CVRF) persist with notable prevalence in patients with Cushing’s disease (CD) after remission: obesity/overweight up to 40%, hypertension (HTA) up to 60%, type 2 diabetes (DM-2) up to 60% and dyslipidemia up to 30% of cases. Persistence of metabolic syndrome in patients with controlled CD seems to be related to the duration of the disease before remission. The aim of this study is to describe the prevalence of CVRF in patients with ...

ea0063p581 | Diabetes, Obesity and Metabolism 2 | ECE2019

Flash glucose monitoring: repercussions in glycemic control

Rebollo-Roman Angel , Alhambra-Exposito Maria-Rosa , Moreno-Moreno Paloma , Alcantara-Laguna Maria , Leon-Idougourram Soraya , Palomares-Ortega Rafael , Galvez-Moreno Maria-Angeles

Introduction: Flash glucose monitoring (FGM) allows non-invasive glucose level assessment. Studies have shown that patients using FGM test their glucose levels more often than those who use traditional blood glucose testing. Given that a higher rate of glucose testing has showed to improve glycemic control our objective was to describe the change in the glycemic control and time in euglycemic range in patients with FGM and the effect of the number of scans in this control....

ea0049ep907 | Neuroendocrinology | ECE2017

Diagnosis, treatment and follow-up of non-functioning pituitary adenomas

Barrera-Martin Ana , Moreno-Moreno Paloma , Alhambra-Exposito Maria-Rosa , Herrera-Martinez Aura-Dulcinea , Rebollo-Roman Angel , Garcia-Jurado Pedro-Blas , Galvez-Moreno Maria-Angeles

Introduction: Non-functioning pituitary adenomas (NFPAs) represent the most common pituitary tumour. They usually appear in the middle age of life, without differences between genders. Mass growth produces the first symptoms so the diagnosis is usually late. Surgery is the first-line treatment with variable success (19-83%). The objective of this study is to evaluate the symptoms, diagnosis, treatment and final state of patients with NFPAs.Methods: Obser...